Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B0a61bbc44e43bccfb5a1ef0332f9579f> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B0a61bbc44e43bccfb5a1ef0332f9579f NCIT_P378 "NCI" @default.
- B0a61bbc44e43bccfb5a1ef0332f9579f type Axiom @default.
- B0a61bbc44e43bccfb5a1ef0332f9579f annotatedProperty IAO_0000115 @default.
- B0a61bbc44e43bccfb5a1ef0332f9579f annotatedSource NCIT_C74089 @default.
- B0a61bbc44e43bccfb5a1ef0332f9579f annotatedTarget "A highly tumor-selective vaccinia virus (vv) with an engineered double deletion (DD) of the thymidine kinase (tk) and vaccinia growth factor genes and additions of both a cytosine deaminase (CD) gene and a somatostatin receptor (SR) gene with potential oncolytic viral activity. The tk and vaccinia growth factor gene deletions in intratumorally administered vaccinia virus (vvDD-CDSR) help to restrict its replication and cytolytic activity to tumor cells with large nucleotide pools and tumor cells with activation of the EGFR-Ras pathway. Addition of the CD gene to the viral genome allows control of oncolytic viral infection through the administration of the prodrug 5-fluorocytosine (5-FC), converted by CD to the antimetabolite 5-fluorouracil (5-FU) in cells infected with this agent. Addition of the SR gene allows anatomical localization of vaccinia virus (vvDD-CDSR) through the use of octreotide scintigraphy." @default.